Sonos (SONO) 10-Q 10 May 23 2023 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Apr. 01, 2023	Apr. 29, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Apr. 01, 2023
Document Transition Report	false
Entity File Number	001-38603
Entity Registrant Name	SONOS, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	03-0479476
Entity Address, Address Line One	614 Chapala Street
Entity Address, City or Town	Santa Barbara
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	93101
City Area Code	805
Local Phone Number	965-300
Title of 12(b) Security	Common Stock, $0.001 par value
Trading Symbol	SONO
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		128,322,498
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Entity Central Index Key	0001314727
Current Fiscal Year End Date	--09-30

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Apr. 01, 2023	Oct. 01, 2022
Current assets:
Cash and cash equivalents	$ 294,873	$ 274,855
Accounts receivable, net of allowances	84,203	101,206
Inventories	326,289	454,288
Prepaids and other current assets	31,474	37,042
Total current assets	736,839	867,391
Property and equipment, net	87,467	86,168
Operating lease right-of-use assets	21,662	28,329
Goodwill	81,501	77,300
Intangible assets, net:
In-process research and development	71,554	64,680
Other intangible assets	23,219	26,384
Deferred tax assets	1,530	1,508
Other noncurrent assets	35,481	36,628
Total assets	1,059,253	1,188,388
Current liabilities:
Accounts payable	183,648	335,758
Accrued expenses	76,387	109,290
Accrued compensation	30,492	23,624
Deferred revenue, current	19,764	27,318
Other current liabilities	41,866	39,649
Total current liabilities	352,157	535,639
Operating lease liabilities, noncurrent	19,606	25,596
Deferred revenue, noncurrent	61,963	56,152
Deferred tax liabilities	11,849	9,642
Other noncurrent liabilities	764	846
Total liabilities	446,339	627,875
Commitments and contingencies (Note 7)
Stockholders’ equity:
Common stock, $0.001 par value	130	130
Treasury stock	(36,462)	(50,896)
Additional paid-in capital	613,505	617,390
Retained earnings (accumulated deficit)	42,022	(2,514)
Accumulated other comprehensive loss	(6,281)	(3,597)
Total stockholders’ equity	612,914	560,513
Total liabilities and stockholders’ equity	$ 1,059,253	$ 1,188,388

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Apr. 01, 2023	Oct. 01, 2022
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 01, 2023	Apr. 02, 2022
Income Statement [Abstract]
Revenue	$ 304,173	$ 399,781	$ 976,752	$ 1,064,262
Cost of revenue	172,555	220,747	560,078	567,843
Gross profit	131,618	179,034	416,674	496,419
Operating expenses
Research and development	80,785	64,947	157,726	126,277
Sales and marketing	63,621	59,955	142,317	143,691
General and administrative	44,438	44,090	87,553	83,816
Total operating expenses	188,844	168,992	387,596	353,784
Operating income (loss)	(57,226)	10,042	29,078	142,635
Other income (expense), net
Interest income	3,181	123	5,149	156
Interest expense	(152)	(90)	(311)	(187)
Other income (expense), net	(2,832)	(2,281)	20,745	(3,683)
Total other income (expense), net	197	(2,248)	25,583	(3,714)
Income (loss) before provision for (benefit from) income taxes	(57,029)	7,794	54,661	138,921
Provision for (benefit from) income taxes	(26,377)	(772)	10,124	6,874
Net income (loss)	(30,652)	8,566	44,537	132,047
Net income (loss) attributable to common stockholders:
Basic and diluted	$ (30,652)	$ 8,566	$ 44,537	$ 132,047
Basic (in USD per share)	$ (0.24)	$ 0.07	$ 0.35	$ 1.03
Diluted (in USD per share)	$ (0.24)	$ 0.06	$ 0.34	$ 0.94
Weighted-average shares used in computing net income (loss) per share attributable to common stockholders:
Basic (in shares)	127,952,875	128,112,234	127,582,560	127,887,530
Diluted (in shares)	127,952,875	139,642,570	132,834,096	140,982,509
Total comprehensive income (loss)
Net income (loss)	$ (30,652)	$ 8,566	$ 44,537	$ 132,047
Change in foreign currency translation adjustment	4,542	100	(2,684)	(260)
Comprehensive income (loss)	$ (26,110)	$ 8,666	$ 41,853	$ 131,787

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Treasury Stock	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Loss
Balance, beginning of period (in shares) at Oct. 02, 2021		128,857,085		(1,871,812)
Balance, beginning of period at Oct. 02, 2021	$ 569,042	$ 129	$ 690,462	$ (50,276)	$ (69,897)	$ (1,376)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock pursuant to equity incentive plans (in shares)		2,030,373
Issuance of common stock pursuant to equity incentive plans	13,232	$ 2	13,230
Retirement of treasury stock (in shares)		(1,010,286)		1,010,286
Retirement of treasury stock		$ (1)	(38,647)	$ 38,648
Repurchase of common stock (in shares)				(1,032,249)
Repurchase of common stock	(31,365)			$ (31,365)
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards (in shares)				(344,198)
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards	(11,882)			$ (11,882)
Stock-based compensation expense	17,459		17,459
Net income (loss)	123,481				123,481
Change in foreign currency translation adjustment	(360)					(360)
Balance, end of period (in shares) at Jan. 01, 2022		129,877,172		(2,237,973)
Balance, ending of period at Jan. 01, 2022	679,607	$ 130	682,504	$ (54,875)	53,584	(1,736)
Balance, beginning of period (in shares) at Oct. 02, 2021		128,857,085		(1,871,812)
Balance, beginning of period at Oct. 02, 2021	569,042	$ 129	690,462	$ (50,276)	(69,897)	(1,376)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	132,047
Change in foreign currency translation adjustment	(260)
Balance, end of period (in shares) at Apr. 02, 2022		129,959,957		(1,808,635)
Balance, ending of period at Apr. 02, 2022	671,684	$ 130	647,871	$ (36,831)	62,150	(1,636)
Balance, beginning of period (in shares) at Jan. 01, 2022		129,877,172		(2,237,973)
Balance, beginning of period at Jan. 01, 2022	679,607	$ 130	682,504	$ (54,875)	53,584	(1,736)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock pursuant to equity incentive plans (in shares)		2,500,969
Issuance of common stock pursuant to equity incentive plans	16,021	$ 2	16,019
Retirement of treasury stock (in shares)		(2,418,184)		2,418,184
Retirement of treasury stock		$ (2)	(71,877)	$ 71,879
Repurchase of common stock (in shares)				(1,611,921)
Repurchase of common stock	(43,115)			$ (43,115)
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards (in shares)				(376,925)
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards	(10,720)			$ (10,720)
Stock-based compensation expense	21,225		21,225
Net income (loss)	8,566				8,566
Change in foreign currency translation adjustment	100					100
Balance, end of period (in shares) at Apr. 02, 2022		129,959,957		(1,808,635)
Balance, ending of period at Apr. 02, 2022	671,684	$ 130	647,871	$ (36,831)	62,150	(1,636)
Balance, beginning of period (in shares) at Oct. 01, 2022		129,823,663		(3,154,940)
Balance, beginning of period at Oct. 01, 2022	560,513	$ 130	617,390	$ (50,896)	(2,514)	(3,597)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock pursuant to equity incentive plans (in shares)		1,973,506
Issuance of common stock pursuant to equity incentive plans	8,103	$ 2	8,101
Retirement of treasury stock (in shares)		(2,293,416)		2,293,416
Retirement of treasury stock		$ (2)	(39,266)	$ 39,268
Repurchase of common stock (in shares)				(849,806)
Repurchase of common stock	(15,043)			$ (15,043)
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards (in shares)				(470,585)
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards	(8,376)			$ (8,376)
Stock-based compensation expense	20,195		20,195
Net income (loss)	75,188				75,188
Change in foreign currency translation adjustment	(7,226)					(7,226)
Balance, end of period (in shares) at Dec. 31, 2022		129,503,753		(2,181,915)
Balance, ending of period at Dec. 31, 2022	633,354	$ 130	606,420	$ (35,047)	72,674	(10,823)
Balance, beginning of period (in shares) at Oct. 01, 2022		129,823,663		(3,154,940)
Balance, beginning of period at Oct. 01, 2022	$ 560,513	$ 130	617,390	$ (50,896)	(2,514)	(3,597)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock pursuant to equity incentive plans (in shares)	1,621,326
Retirement of treasury stock (in shares)	(3,613,807)
Repurchase of common stock (in shares)	(1,616,155)
Net income (loss)	$ 44,537
Change in foreign currency translation adjustment	(2,684)
Balance, end of period (in shares) at Apr. 01, 2023		130,355,273		(2,085,833)
Balance, ending of period at Apr. 01, 2023	612,914	$ 130	613,505	$ (36,462)	42,022	(6,281)
Balance, beginning of period (in shares) at Dec. 31, 2022		129,503,753		(2,181,915)
Balance, beginning of period at Dec. 31, 2022	633,354	$ 130	606,420	$ (35,047)	72,674	(10,823)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock pursuant to equity incentive plans (in shares)		2,171,911
Issuance of common stock pursuant to equity incentive plans	9,479	$ 1	9,478
Retirement of treasury stock (in shares)		(1,320,391)		1,320,391
Retirement of treasury stock		$ (1)	(23,418)	$ 23,419
Repurchase of common stock (in shares)				(766,349)
Repurchase of common stock	(15,011)			$ (15,011)
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards (in shares)				(457,960)
Repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards	(9,823)			$ (9,823)
Stock-based compensation expense	21,025		21,025
Net income (loss)	(30,652)				(30,652)
Change in foreign currency translation adjustment	4,542					4,542
Balance, end of period (in shares) at Apr. 01, 2023		130,355,273		(2,085,833)
Balance, ending of period at Apr. 01, 2023	$ 612,914	$ 130	$ 613,505	$ (36,462)	$ 42,022	$ (6,281)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Cash flows from operating activities
Net income	$ 44,537	$ 132,047
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	22,845	18,792
Impairment and abandonment charges	4,846
Stock-based compensation expense	41,220	38,684
Other	13,232	4,357
Deferred income taxes	1,358	(129)
Foreign currency transaction (gains) losses	(14,126)	2,267
Changes in operating assets and liabilities:
Accounts receivable	16,932	(12,786)
Inventories	118,032	(86,153)
Other assets	5,481	(6,082)
Accounts payable and accrued expenses	(186,194)	51,643
Accrued compensation	6,108	(45,084)
Deferred revenue	(4,484)	(11,834)
Other liabilities	(463)	(3,348)
Net cash provided by operating activities	69,324	82,374
Cash flows from investing activities
Purchases of property and equipment, and intangible assets	(23,403)	(15,665)
Cash paid for acquisitions, net of acquired cash		(27,101)
Net cash used in investing activities	(23,403)	(42,766)
Cash flows from financing activities
Payments for debt issuance costs		(929)
Payments for repurchase of common stock	(30,054)	(74,482)
Proceeds from exercise of common stock options	17,584	29,254
Payments for repurchase of common stock related to shares withheld for tax in connection with vesting of stock awards	(18,199)	(22,601)
Net cash used in financing activities	(30,669)	(68,758)
Effect of exchange rate changes on cash and cash equivalents	4,766	(4,207)
Net increase (decrease) in cash and cash equivalents	20,018	(33,357)
Cash and cash equivalents
Beginning of period	274,855	640,101
End of period	294,873	606,744
Supplemental disclosure
Cash paid for interest	330	85
Cash paid for taxes, net of refunds	6,399	8,916
Cash paid for amounts included in the measurement of lease liabilities	7,219	7,800
Supplemental disclosure of non-cash investing and financing activities
Purchases of property and equipment in accounts payable and accrued expenses	8,393	7,869
Right-of-use assets obtained in exchange for new operating lease liabilities	$ 711	$ 2,245

Business Overview and Basis of

Business Overview and Basis of Presentation	6 Months Ended
	Apr. 01, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business Overview and Basis of Presentation	1. Business Overview and Basis of Presentation Description of business Sonos, Inc. and its wholly owned subsidiaries (collectively, “Sonos,” the “Company,” “we,” “us” or “our”) designs, develops, manufactures, and sells audio products and services. The Sonos sound system provides customers with an immersive listening experience created by the design of its speakers and components, a proprietary software platform, and the ability to stream content from a variety of sources over the customer’s wireless network or over Bluetooth. The Company’s products are sold through third-party physical retailers, including custom installers of home audio systems, select e-commerce retailers, and its website, sonos.com. The Company’s products are distributed in over 60 countries through its wholly owned subsidiaries: Sonos Europe B.V. in the Netherlands, Beijing Sonos Technology Co. Ltd. in China, Sonos Japan GK in Japan, and Sonos Australia Pty Ltd. in Australia. Basis of presentation and preparation The accompanying condensed consolidated financial statements are unaudited. The condensed consolidated balance sheet as of October 1, 2022, has been derived from the audited consolidated financial statements of the Company. The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information and the applicable rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all the information and footnotes required by U.S. GAAP for annual financial statements. They should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended October 1, 2022, (the “Annual Report”), filed with the SEC on November 23, 2022. In management’s opinion, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of only normal recurring adjustments, necessary for the fair statement of the Company’s financial position, its results of operations, and its cash flows for the interim periods presented. The results of operations for the three and six months ended April 1, 2023, are not necessarily indicative of the results to be expected for the full fiscal year or any other period. The Company operates on a 52- week or 53- week fiscal year ending on the Saturday nearest September 30 each year. The Company’s fiscal year is divided into four quarters of 13 weeks, each beginning on a Sunday and containing two 4-week periods followed by a 5-week period. An additional week is included in the fourth fiscal quarter approximately every five years to realign fiscal quarters with calendar quarters. This last occurred in the fourth quarter of the Company’s fiscal year ended October 3, 2020, and will reoccur in the fiscal year ending October 3, 2026. The six months ended April 1, 2023, and April 2, 2022 , spanned 26 weeks each. As used in this Quarterly Report on Form 10-Q, “fiscal 2023” refers to the fiscal year ending September 30, 2023, “fiscal 2022” refers to the fiscal year ended October 1, 2022, "fiscal 2021” refers to the fiscal year ended October 2, 2021, and "fiscal 2020" refers to the fiscal year ended October 3, 2020. Use of estimates and judgments The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, the Company evaluates its estimates and judgments compared to historical experience and expected trends. The Company has considered the impacts of the COVID-19 pandemic when developing its estimates and assumptions noted above. The impacts of, and uncertainty related to, the COVID-19 pandemic and its expected duration persist. Actual results and outcomes may differ from management's estimates and assumptions.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Apr. 01, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies There have been no changes in the Company’s significant accounting policies, recently adopted accounting pronouncements or recent accounting pronouncements pending adoption from those disclosed in the Annual Report, except as noted below. Recent accounting pronouncements pending adoption In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of Effects of Reference Rate Reform on Financial Reporting, and then issued subsequent amendments to the initial guidance under ASU No. 2021-01 and ASU No. 2022-06 (collectively Topic 848). Topic 848 provides practical expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, derivatives, and other transactions affected by reference rate reform if certain criteria are met. The expedients and exceptions provided by the amendments in this update apply only to contracts, hedging relationships, derivatives, and other transactions that reference the London interbank offered rate (“LIBOR”) or another reference rate expected to be discontinued as a result of reference rate reform. Topic 848 is currently effective and upon adoption may be applied prospectively to contract modifications and hedging relationships made on or before December 31, 2024. The Company is currently evaluating the pronouncement to determine the impact it may have on the Company's consolidated financial statements.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Apr. 01, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	3. Fair Value Measurements The carrying values of the Company’s financial instruments, including accounts receivable and accounts payable, approximate their fair values due to the short period of time to maturity or repayment. The following table summarizes fair value measurements by level for the assets measured at fair value on a recurring basis as of April 1, 2023, and October 1, 2022: April 1, 2023 Level 1 Level 2 Level 3 Total (In thousands) Assets: Money market funds (cash equivalents) $ 223,579 $ — $ — $ 223,579 October 1, 2022 Level 1 Level 2 Level 3 Total (In thousands) Assets: Money market funds (cash equivalents) $ 187,170 $ — $ — $ 187,170

Revenue and Geographic Informat

Revenue and Geographic Information	6 Months Ended
	Apr. 01, 2023
Revenue from Contract with Customer [Abstract]
Revenue and Geographic Information	4. Revenue and Geographic Information Disaggregation of revenue Revenue is attributed to each region based on ship-to address, and also includes the applicable service revenue for software upgrades and cloud-based services attributable to each region. Revenue by region is as follows: Three Months Ended Six Months Ended April 1, April 2, April 1, April 2, (In thousands) Americas $ 196,533 $ 238,193 $ 593,097 $ 612,006 Europe, Middle East and Africa (“EMEA”) 89,054 128,431 329,494 373,912 Asia Pacific (“APAC”) 18,586 33,157 54,161 78,344 Total revenue $ 304,173 $ 399,781 $ 976,752 $ 1,064,262 Revenue is attributed to individual countries based on ship-to address and also includes the applicable service revenue for software upgrades and cloud-based services attributable to each country. Revenue by significant countries is as follows: Three Months Ended Six Months Ended April 1, April 2, April 1, April 2, (In thousands) United States $ 181,877 $ 219,082 $ 547,851 $ 566,729 Other countries 122,296 180,699 428,901 497,533 Total revenue $ 304,173 $ 399,781 $ 976,752 $ 1,064,262 Revenue by product category also includes the applicable service revenue for software upgrades and cloud-based services attributable to each product category. Revenue by major product category is as follows: Three Months Ended Six Months Ended April 1, April 2, April 1, April 2, (In thousands) Sonos speakers $ 241,180 $ 317,734 $ 780,377 $ 819,620 Sonos system products 44,091 61,220 158,525 195,965 Partner products and other revenue 18,902 20,827 37,850 48,677 Total revenue $ 304,173 $ 399,781 $ 976,752 $ 1,064,262

Balance Sheet Components

Balance Sheet Components	6 Months Ended
	Apr. 01, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Components	5. Balance Sheet Components Accounts receivable, net of allowances Accounts receivable, net of allowances, consist of the following: April 1, October 1, (In thousands) Accounts receivable $ 112,019 $ 127,523 Allowance for credit losses ( 3,171 ) ( 2,744 ) Allowance for sales incentives ( 24,645 ) ( 23,573 ) Accounts receivable, net of allowances $ 84,203 $ 101,206 Inventories Inventories, net, consist of the following: April 1, October 1, (In thousands) Finished goods $ 274,459 $ 406,657 Component parts 51,830 47,631 Inventories $ 326,289 $ 454,288 The Company writes down inventory as a result of excess and obsolete inventories or when it believes that the net realizable value of inventories is less than the carrying value. As of April 1, 2023, and October 1, 2022, inventory write-downs were $ 19.3 million and $ 8.8 million, respectively. Goodwill The following table presents the changes in carrying amount of goodwill during the six months ended April 1, 2023: (In thousands) Balance as of October 1, 2022 $ 77,300 Effect of exchange rate changes on goodwill 4,201 Balance as of April 1, 2023 $ 81,501 Intangible assets The following table reflects the changes in the net carrying amount of the components of intangible assets associated with the Company's acquisition activity: April 1, 2023 Gross Carrying Amount Accumulated Amortization Impact of FX Net Carrying Value Weighted-Average Remaining Life (In thousands, except weighted-average remaining life) Trade name $ 451 $ ( 71 ) $ ( 1 ) $ 379 5.00 Technology-based 31,480 ( 8,640 ) — 22,840 5.19 Total finite-lived intangible assets 31,931 ( 8,711 ) ( 1 ) 23,219 5.19 In-process research and development not subject to amortization 71,759 — ( 205 ) 71,554 Total intangible assets $ 103,690 $ ( 8,711 ) $ ( 206 ) $ 94,773 The following table summarizes the estimated future amortization expense of the Company's intangible assets as of April 1, 2023: Fiscal years ending Future Amortization Expense (In thousands) Remainder of fiscal 2023 $ 2,986 2024 5,971 2025 3,371 2026 3,041 2027 3,026 2028 and there after 4,824 Total future amortization expense $ 23,219 Cloud Computing Arrangements The Company incurs costs to implement cloud computing arrangements that are hosted by a third-party vendor. Implementation costs incurred during the application development stage are capitalized until the software is ready for its intended use. The costs are then amortized on a straight-line basis over the term of the associated hosting arrangement and are recognized as an operating expense within the condensed consolidated statements of operations and comprehensive income (loss). Beginning in fiscal 2020, and continuing through April 2022, the Company conducted activities to replace its legacy enterprise resource management system in order to accommodate the Company's expanding operations. In May 2022, the Company went live with its implementation of a new enterprise resource planning ("ERP") system. Capitalized costs, net of accumulated amortization, were $ 19.8 million and $ 21.7 million as of April 1, 2023, and October 1, 2022, respectively, and are reported as a component of other noncurrent assets on the Company's condensed consolidated balance sheets. Amortization expenses for implementation costs for cloud-based computing arrangements for three and six months ended April 1, 2023 were $ 1.0 million and $ 1.9 million, respectively. Accumulated amortization was $ 4.4 million and $ 2.5 million as of April 1, 2023, and October 1, 2022, respectively. Accrued expenses Accrued expenses consisted of the following: April 1, October 1, (In thousands) Accrued inventory and supply chain costs $ 40,213 $ 51,011 Accrued general and administrative expenses 14,811 21,634 Accrued advertising and marketing 10,982 21,292 Accrued taxes 5,076 7,081 Accrued product development 3,313 8,168 Other accrued payables 1,992 104 Total accrued expenses $ 76,387 $ 109,290 Deferred revenue Amounts invoiced in advance of revenue recognition are recorded as deferred revenue on the condensed consolidated balance sheets. Deferred revenue primarily relates to revenue allocated to unspecified software upgrades and cloud-based services. Recognition of revenue as of April 1, 2023, includes $ 9.2 million of deferred revenue from the fourth quarter of fiscal 2022, related to newly launched products sold to resellers not recognized as revenue until the date of general availability was reached, which was the first quarter of fiscal 2023. Recognition of revenue as of April 2, 2022, includes $ 18.8 million of deferred revenue from the fourth quarter of fiscal 2021, related to newly launched products sold to resellers not recognized as revenue until the date of general availability was reached, which was the first quarter of fiscal 2022. The following table presents the changes in the Company’s deferred revenue for the six months ended April 1, 2023, and April 2, 2022: April 1, April 2, (In thousands) Deferred revenue, beginning of period $ 83,470 $ 89,498 Recognition of revenue included in beginning of period deferred revenue ( 16,186 ) ( 28,927 ) Revenue deferred, net of revenue recognized on contracts in the respective period 14,443 16,063 Deferred revenue, end of period $ 81,727 $ 76,634 The Company expects the following recognition of deferred revenue as of April 1, 2023: For the fiscal years ending 2023 2024 2025 2026 2027 and Total (In thousands) Deferred revenue expected to be recognized $ 10,391 $ 18,190 $ 15,892 $ 13,497 $ 23,757 $ 81,727 Other current liabilities Other current liabilities consist of the following: April 1, October 1, (In thousands) Reserve for returns $ 15,674 $ 18,263 Short-term operating lease liabilities 10,949 10,532 Warranty liability 8,993 5,771 Other 6,250 5,083 Total other current liabilities $ 41,866 $ 39,649 The following table presents the changes in the Company’s warranty liability for the six months ended April 1, 2023, and April 2, 2022: April 1, April 2, (In thousands) Warranty liability, beginning of period $ 5,771 $ 5,604 Provision for warranties issued during the period 7,892 7,082 Settlements of warranty claims during the period ( 4,670 ) ( 3,930 ) Warranty liability, end of period $ 8,993 $ 8,756

Debt

Debt	6 Months Ended
	Apr. 01, 2023
Debt Disclosure [Abstract]
Debt	6. Debt On October 13, 2021, the Company entered into a Revolving Credit Agreement with JPMorgan Chase Bank, N.A., as the administrative agent, and the lenders party thereto (the “Revolving Credit Agreement”). The Revolving Credit Agreement provides for (i) a five-year senior secured revolving credit facility in the amount of up to $ 100.0 million and (ii) an uncommitted incremental facility subject to certain conditions. Proceeds are to be used for working capital and general corporate purposes. The facility may be drawn as an Alternative Base Rate Loan (at 1.00 % plus an applicable margin) or Eurocurrency Loans (at LIBOR plus an applicable margin). The Company must also pay (i) an unused commitment fee ranging from 0.200 % to 0.275 % per annum of the average daily unused portion of the aggregate revolving credit commitment under the agreement and (ii) a per annum fee equal to the applicable margin over LIBOR multiplied by the aggregate face amount of outstanding letters of credit. As of April 1, 2023 , the Company did not have any outstanding borrowings and had $ 3.0 million in undrawn letters of credit that reduce the availability under the Revolving Credit Agreement. The Company’s obligations under the Revolving Credit Agreement are secured by substantially all of the Company’s assets. The Revolving Credit Agreement contains customary representations and warranties, customary affirmative and negative covenants, a financial covenant that is tested quarterly and requires the Company to maintain a certain consolidated leverage ratio, and customary events of default. As of April 1, 2023 , the Company was in compliance with all financial covenants under the Revolving Credit Agreement.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Apr. 01, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	7. Commitments and Contingencies Commitments to suppliers At April 1, 2023 , the Company's commitments to suppliers were estimated to be approximately $ 169 million, the majority of which is expected to be paid in the next two years , with approximately $ 106 million to $ 141 million expected to be paid in the next twelve months. These commitments are related to electrical components that are specific to Sonos products, and for which the Company typically participates in negotiations directly with the suppliers, and included 1) contractual obligations to third-party manufacturers and suppliers, 2) the inventory owned by contract manufacturers procured to manufacture Sonos products, and 3) purchase commitments made by contract manufacturers to their upstream suppliers. Legal proceedings From time to time, the Company is involved in legal proceedings in the ordinary course of business, including claims relating to employee relations, business practices, and patent infringement. Litigation can be expensive and disruptive to normal business operations. Moreover, the results of complex legal proceedings are difficult to predict, and the Company’s view of these matters may change in the future as the litigation and events related thereto unfold. The Company expenses legal fees as incurred. The Company records a provision for contingent losses when it is both probable that a liability will be incurred and the amount of the loss can be reasonably estimated. An unfavorable outcome to any legal matter, if material, could have an adverse effect on the Company’s operations or its financial position, liquidity or results of operations. The Company’s Lawsuits Against Google: On January 7, 2020, the Company filed a complaint with the U.S. International Trade Commission ("ITC") against Alphabet Inc. ("Alphabet") and Google LLC ("Google") and a counterpart lawsuit in the U.S. District Court for the Central District of California against Google. The complaint and lawsuit each allege infringement by Alphabet and Google of certain Sonos patents related to its smart speakers and related technology. The counterpart lawsuit is stayed pending completion of the ITC investigation and appeal thereof. The ITC concluded its investigation in January 2022, finding all five of the Company’s asserted patents to be valid and infringed by Google, and further finding that one redesign per patent proposed by Google would avoid infringement. The ITC issued a limited exclusion order and a cease-and-desist order with respect to Google’s infringing products. The outcome of the ITC investigation is currently being appealed by the Company and Google. On September 29, 2020, the Company filed another lawsuit against Google alleging infringement of additional Sonos patents and seeking monetary damages and other non-monetary relief. This suit is pending in the U.S. District Court for the Northern District of California. In this lawsuit, Google has countersued the Company alleging breach of contract and conversion against the Company in connection with Google and the Company’s collaboration in 2013. The Company disputes these Google counterclaims. Of the four patents asserted in the case, the judge has already concluded that Google infringes one asserted patent and that this patent is not invalid. The judge has also ruled that another asserted patent is not infringed by Google and is invalid and that another patent is invalid. In light of these rulings, Google is no longer pursuing its countersuit. The jury trial for the case started on May 8, 2023. On December 1, 2020, the Company filed a lawsuit against two Google foreign subsidiaries in the regional court of Hamburg, Germany, alleging infringement of a Sonos patent seeking non-monetary relief. The Company has since withdrawn this action after having received some preliminary relief. Google’s Lawsuits Against the Company: On June 11, 2020, Google filed a lawsuit in the U.S. District Court for the Northern District of California against the Company alleging infringement by the Company of five Google patents and seeking monetary damages and other non-monetary relief. Four of these patents have since been found invalid by the court or by the U.S. Patent and Trademark Office, or have been withdrawn from the case by Google. In this lawsuit, one patent remains asserted against the Company. No trial date is set. On June 12, 2020, Google filed lawsuits in District Court Munich I against Sonos Europe B.V. and Sonos, Inc., alleging infringement of two Google patents and seeking monetary damages and an injunction preventing sales of allegedly infringing products. In March 2021, the District Court Munich stayed the case for infringement of one Google patent pending the outcome of a nullity action concerning the validity of that patent. In June 2021, the Munich court issued a decision dismissing Google's complaint regarding the other Google patent for lack of infringement by the Company. Google has appealed the Munich court's ruling, which is pending. On August 21, 2020, Google filed a lawsuit against the Company in Canada alleging infringement of one Google patent. On July 26, 2022, the Canadian court ruled that the Company does not infringe this patent after a trial on the merits. Google has appealed the Canadian court’s ruling, which is pending. On August 21, 2020, Google filed a lawsuit against Sonos Europe B.V. and Sonos, Inc. in France, alleging infringement of two Google patents and seeking monetary damages and an injunction preventing sales of allegedly infringing products. In February 2021, Google withdrew its infringement allegations regarding one patent in view of prior art brought to the attention of the court by the Company. In March 2022, the French trial court ruled for the Company on Google's other asserted patent. Google has appealed the French trial court's ruling, which is pending. On August 21, 2020, Google filed a lawsuit against Sonos Europe B.V. and Sonos, Inc. in the Netherlands alleging infringement of a Google patent seeking an injunction preventing sales of allegedly infringing products. In October 2022, the Netherlands court ruled that the Company does not infringe Google’s patent. In September 2020, Google filed a lawsuit against Sonos Europe B.V. in the Netherlands, alleging infringement of a Google patent seeking an injunction preventing sales of allegedly infringing products. In February 2022, the Court rejected Google's claims concerning this patent. Google has appealed this decision, which is pending. On August 8, 2022, Google filed two complaints with the ITC against the Company and two counterpart lawsuits in the Northern District of California against the Company, collectively alleging infringement by the Company of seven Google patents generally related to wireless charging, device setup, and voice control, and seeking monetary damages and other non-monetary relief. The ITC investigations are currently pending while the counterpart lawsuits are stayed pending completion of the ITC investigations. The ITC has terminated the investigation as to one Google patent as a result of imminent expiration of that Google patent. One of the two ITC investigations is scheduled for an oral hearing in June 2023 and scheduled for a final decision in January 2024, while the other of the two ITC investigations is scheduled for an oral hearing in July 2023 and scheduled for a final decision in May 2024. Implicit On March 10, 2017, Implicit, LLC (“Implicit”) filed a patent infringement action in the United States District Court, District of Delaware against the Company. Implicit is asserting that the Company infringed on two patents in this case. The Company denies the allegations. There is no assurance of a favorable outcome and the Company’s business could be adversely affected as a result of a finding that the Company patents-in-suit are invalid and/or unenforceable. The Company is involved in certain other litigation matters not listed above but does not consider these matters to be material either individually or in the aggregate at this time. The Company’s view of the matters not listed may change in the future as the litigation and events related thereto unfold. Tariff refunds On May 13, 2020, the Company was granted a temporary exclusion from the August 2019 Section 301 Tariff Action (List 4A) ("Section 301 tariffs"), eliminating the tariffs on the Company's component products imported from China until August 31, 2020. The exclusion for the Company’s component products was not extended past August 31, 2020, with the Section 301 tariffs for our component products automatically reinstated on September 1, 2020. On July 23, 2020, the Company was granted a temporary exclusion from Section 301 tariffs, eliminating the tariffs on the Company’s core speaker products imported from China until August 31, 2020. These exemptions entitled the Company to refunds for tariffs paid from September 2019 through December 2020. On August 28, 2020, the United States Trade Representative ("USTR") granted an extension through December 31, 2020, of the exclusion for the Company’s core speaker products, with the Section 301 tariffs for our core speaker products automatically reinstated on January 1, 2021. On March 23, 2022, the Company was granted an exclusion extension from the Section 301 tariffs, eliminating tariffs on the Company’s core speaker products, including certain new product introductions, imported from China from April 13, 2022 through December 31, 2022. This exemption entitled the Company to refunds for tariffs paid from October 12, 2021 through April 12, 2022. On December 16, 2022, the USTR granted an extension through September 30, 2023, of the exclusion for the Company's core speaker products. Tariff refund claims are subject to review and approval by the U.S. Customs and Border Protection. For the three and six months ended April 1, 2023, the Company recognized $ 2.0 million and $ 6.4 million, respectively, in refunds based upon acceptance of the Company's refund request, recognized as a reduction to cost of revenue. As of April 1, 2023, the remaining refunds the Company expected to recover totaled approximately $ 4.1 million, for tariffs paid from September 2019 through December 2020, and from October 12, 2021 through April 12, 2022. The Company did not record these potential refunds due to uncertainty of the timing of acceptance of approval, but such refunds will be recognized as a reduction to cost of revenue if and when acceptance occurs.

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Apr. 01, 2023
Equity [Abstract]
Stockholders' Equity	8. Stockholders' Equity On November 16, 2022, the Board of Directors (the "Board") authorized a common stock repurchase program of up to $ 100.0 million. During the six months ended April 1, 2023, the Company repurchased 1,616,155 shares for an aggregate purchase price of $ 30.1 million at an average price of $ 18.58 per share under the repurchase program. The Company had $ 69.9 million available for share repurchases under the repurchase program as of April 1, 2023. Treasury stock during the six months ended April 1, 2023, included shares withheld to satisfy employees' tax withholding requirements in connection with vesting of stock awards. Additionally, during the six months ended April 1, 2023, the Company retired 3,613,807 shares of treasury stock.

Stock-based Compensation

Stock-based Compensation	6 Months Ended
	Apr. 01, 2023
Share-Based Payment Arrangement [Abstract]
Stock-based Compensation	9. Stock-based Compensation 2018 Equity Incentive Plan In July 2018, the Board adopted the 2018 Equity Incentive Plan (the “2018 Plan”). The 2018 Plan became effective in connection with the Company's initial public offering ("IPO"). The number of shares reserved for issuance under the 2018 Plan increases automatically on January 1 of each year beginning in 2019 and continuing through 2028 by a number of shares of common stock equal to the lesser of (x) 5 % of the total outstanding shares of the Company’s common stock and common stock equivalents as of the immediately preceding December 31 (rounded to the nearest whole share) and (y) a number of shares determined by the Company's Board. Stock options Pursuant to the 2018 Plan, the Company issues stock options to employees and directors. The option price, number of shares, and grant date are determined at the discretion of the Board. For so long as the option holder performs services for the Company, the options generally vest over 48 months , on a monthly or quarterly basis, with certain options subject to an initial annual cliff vest, and are exercisable for a period not to exceed ten years from the date of grant. The summary of the Company’s stock option activity is as follows: Number of Options Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value (In years) (In thousands) Outstanding at October 1, 2022 10,802,882 $ 13.37 4.5 $ 10,956 Exercised ( 1,621,326 ) 10.85 Forfeited ( 20,943 ) 15.19 Outstanding at April 1, 2023 9,160,613 $ 13.82 4.1 $ 53,162 As of April 1, 2023 , all outstanding stock options have vested and the Company had no unrecognized stock-based compensation expense related to stock options. As of October 1, 2022, the Company had $ 0.4 million of unrecognized stock-based compensation expense related to stock options, which are expected to be recognized over weighted-average periods of 0.2 years. Restricted stock units ("RSU") Pursuant to the 2018 Plan, the Company issues RSUs to employees and directors. RSUs vest quarterly over the service period, which is generally four years , with certain awards subject to an initial annual cliff vest. The summary of the Company’s RSU activity is as follows : Number of Units Weighted-Average Grant Date Fair Value Aggregate Intrinsic Value (In thousands) Outstanding at October 1, 2022 8,308,177 $ 19.25 $ 115,484 Granted 4,852,623 17.54 Released ( 2,273,828 ) 16.23 Forfeited ( 607,619 ) 18.19 Outstanding at April 1, 2023 10,279,353 $ 19.17 $ 201,681 At April 1, 2023 Units expected to vest 8,746,943 $ 19.06 $ 171,615 As of April 1, 2023, and October 1, 2022, the Company had $ 148.2 million and $ 120.6 million of unrecognized stock-based compensation expense related to RSUs, which are expected to be recognized over weighted-average periods of 2.7 and 2.5 years, respectively. Performance stock units ("PSU") Pursuant to the 2018 Plan, the Company has issued and may issue certain PSUs that vest on the satisfaction of service and performance conditions. The number of outstanding PSUs is based on the target number of share awards. The number of shares vested at the end of the performance period is based on achievement of performance conditions and may include adjustments to reflect the extent to which the corresponding performance goals have been achieved. In the first half of fiscal 2023, the number of shares vested included performance achievement adjustments of a net reduction of 12,895 units. The summary of the Company’s PSU activity is as follows: Number of Units Weighted-Average Grant Date Fair Value Aggregate Intrinsic Value (In thousands) Outstanding at October 1, 2022 398,077 $ 26.96 $ 5,533 Granted 249,370 17.54 Vested ( 263,158 ) 26.26 Forfeited ( 51,292 ) 20.49 Outstanding at April 1, 2023 332,997 $ 21.46 $ 6,533 As of April 1, 2023, and October 1, 2022, the Company had $ 2.0 million and $ 0.4 million of unrecognized stock-based compensation expense related to PSUs, which are expected to be recognized over weighted-average periods of 1.7 and 0.6 years, respectively. Stock-based compensation Total stock-based compensation expense by functional category was as follows: Three Months Ended Six Months Ended April 1, April 2, April 1, April 2, (In thousands) Cost of revenue $ 581 $ 377 $ 1,151 $ 705 Research and development 9,565 8,091 18,716 14,829 Sales and marketing 4,475 4,177 8,588 7,824 General and administrative 6,404 8,580 12,765 15,326 Total stock-based compensation expense $ 21,025 $ 21,225 $ 41,220 $ 38,684

Income Taxes

Income Taxes	6 Months Ended
	Apr. 01, 2023
Income Tax Disclosure [Abstract]
Income Taxes	10. Income Taxes The Company’s tax provision and the resulting effective tax rate for interim periods is generally determined based upon its estimated annual effective tax rate (“AETR”), adjusted for the effect of discrete items arising in that quarter. The impact of such inclusions could result in a higher or lower effective tax rate during a quarter, based upon the mix and timing of actual earnings or losses versus annual projections. In each quarter, the Company updates its estimate of the AETR, and if the estimated AETR changes, a cumulative adjustment is made in that quarter. The Company recorded a benefit from income taxes of $ 26.4 million and of $ 0.8 million for the three months ended April 1, 2023, and April 2, 2022, respectively, related to U.S. and non-U.S. income taxes. The Company recorded a provision for income taxes of $ 10.1 million and $ 6.9 million for the six months ended April 1, 2023, and April 2, 2022, respectively. For the three and six months ended April 1, 2023, the Company calculated its U.S. income tax provision using the discrete method as though the interim year-to-date period was an annual period. The application of the AETR method generally required by ASC 740 was impractical for the U.S. interim tax provision given that normal deviations in the projected pre-tax net income (loss) in the U.S. could have resulted in a disproportionate and unreliable effective tax rate under the AETR method. For the three and six months ended April 1, 2023, the Company's U.S. tax expense was adversely impacted by the requirement to capitalize and amortize research and development expenses under Section 174 of the U.S. Internal Revenue Code (“Section 174”) as the Company recorded a U.S. current tax expense with no corresponding deferred tax benefit due to the valuation allowance maintained against its U.S. deferred tax assets. For the three and six months ended April 1, 2023, the Company concluded that a full valuation allowance on its deferred tax assets in the U.S. continued to be appropriate considering cumulative pre-tax losses in recent years and uncertainty with respect to future taxable income. Release of the valuation allowance in the U.S. would result in a benefit to income tax expense for the period the release is recorded, which could have a material impact on net earnings. The timing and amount of the potential valuation allowance release are subject to significant management judgment, as well as prospective earnings in the U.S.

Net Income (Loss) Per Share

Net Income (Loss) Per Share	6 Months Ended
	Apr. 01, 2023
Earnings Per Share [Abstract]
Net Income (Loss) Per Share	11. Net Income (Loss) Per Share Basic net income (loss) per share attributable to common stockholders is calculated by dividing net income (loss) attributable to common stockholders by the weighted-average number of shares of common stock outstanding less shares subject to repurchase. Diluted net income (loss) per share attributable to common stockholders adjusts the basic net income (loss) per share attributable to common stockholders and the weighted-average number of shares of common stock outstanding for the potentially dilutive impact of stock awards, using the treasury stock method. The following table sets forth the computation of the Company’s basic and diluted net income (loss) per share attributable to common stockholders: Three Months Ended Six Months Ended April 1, April 2, April 1, April 2, (In thousands, except share and per share data) Numerator: Net income (loss) attributable to common stockholders - basic and diluted $ ( 30,652 ) $ 8,566 $ 44,537 $ 132,047 Denominator: Weighted-average shares of common stock—basic 127,952,875 128,112,234 127,582,560 127,887,530 Effect of potentially dilutive stock options — 6,367,917 2,263,141 7,265,077 Effect of RSUs — 4,976,580 2,941,691 5,641,563 Effect of PSUs — 185,839 46,704 188,339 Weighted-average shares of common stock—diluted 127,952,875 139,642,570 132,834,096 140,982,509 Net income (loss) per share attributable to common stockholders: Basic $ ( 0.24 ) $ 0.07 $ 0.35 $ 1.03 Diluted $ ( 0.24 ) $ 0.06 $ 0.34 $ 0.94 The following potentially dilutive shares were excluded from the computation of diluted net income (loss) per share attributable to common stockholders because including them would have been antidilutive: Three Months Ended Six Months Ended April 1, April 2, April 1, April 2, Stock options to purchase common stock 9,606,088 6,360,832 7,753,514 6,099,887 Restricted stock units 11,016,316 5,024,253 7,629,223 4,277,081 Performance stock units 251,004 115,668 123,142 113,169 Total 20,873,408 11,500,753 15,505,879 10,490,137

Retirement Plans

Retirement Plans	6 Months Ended
	Apr. 01, 2023
Retirement Benefits [Abstract]
Retirement Plans	12. Retirement Plans The Company has a defined contribution 401(k) plan (the "401(k) Plan") for the Company’s U.S.-based employees, as well as various defined contribution plans for its international employees. Eligible U.S. employees may make tax-deferred contributions under the 401(k) plan but are limited to the maximum annual dollar amount allowable under the Internal Revenue Code of 1986, as amended (the "Code"). The Company matches contributions towards the 401(k) Plan and international defined contribution plans. The Company's matching contributions totaled $ 2.4 million and $ 2.1 million for the three months ended April 1, 2023, and April 2, 2022, respectively. The Company's matching contributions totaled $ 4.7 million and $ 4.0 million for the six months ended April 1, 2023, and April 2, 2022 , respectively.

Business Overview and Basis o_2

Business Overview and Basis of Presentation (Policies)	6 Months Ended
	Apr. 01, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation and preparation	Basis of presentation and preparation The accompanying condensed consolidated financial statements are unaudited. The condensed consolidated balance sheet as of October 1, 2022, has been derived from the audited consolidated financial statements of the Company. The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information and the applicable rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all the information and footnotes required by U.S. GAAP for annual financial statements. They should be read in conjunction with the consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended October 1, 2022, (the “Annual Report”), filed with the SEC on November 23, 2022. In management’s opinion, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of only normal recurring adjustments, necessary for the fair statement of the Company’s financial position, its results of operations, and its cash flows for the interim periods presented. The results of operations for the three and six months ended April 1, 2023, are not necessarily indicative of the results to be expected for the full fiscal year or any other period. The Company operates on a 52- week or 53- week fiscal year ending on the Saturday nearest September 30 each year. The Company’s fiscal year is divided into four quarters of 13 weeks, each beginning on a Sunday and containing two 4-week periods followed by a 5-week period. An additional week is included in the fourth fiscal quarter approximately every five years to realign fiscal quarters with calendar quarters. This last occurred in the fourth quarter of the Company’s fiscal year ended October 3, 2020, and will reoccur in the fiscal year ending October 3, 2026. The six months ended April 1, 2023, and April 2, 2022 , spanned 26 weeks each. As used in this Quarterly Report on Form 10-Q, “fiscal 2023” refers to the fiscal year ending September 30, 2023, “fiscal 2022” refers to the fiscal year ended October 1, 2022, "fiscal 2021” refers to the fiscal year ended October 2, 2021, and "fiscal 2020" refers to the fiscal year ended October 3, 2020.
Use of estimates and judgment	Use of estimates and judgments The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments that affect the amounts reported and disclosed in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, the Company evaluates its estimates and judgments compared to historical experience and expected trends. The Company has considered the impacts of the COVID-19 pandemic when developing its estimates and assumptions noted above. The impacts of, and uncertainty related to, the COVID-19 pandemic and its expected duration persist. Actual results and outcomes may differ from management's estimates and assumptions.
Recently adopted accounting pronouncements and recent accounting pronouncements pending adoption	Recent accounting pronouncements pending adoption In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of Effects of Reference Rate Reform on Financial Reporting, and then issued subsequent amendments to the initial guidance under ASU No. 2021-01 and ASU No. 2022-06 (collectively Topic 848). Topic 848 provides practical expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, derivatives, and other transactions affected by reference rate reform if certain criteria are met. The expedients and exceptions provided by the amendments in this update apply only to contracts, hedging relationships, derivatives, and other transactions that reference the London interbank offered rate (“LIBOR”) or another reference rate expected to be discontinued as a result of reference rate reform. Topic 848 is currently effective and upon adoption may be applied prospectively to contract modifications and hedging relationships made on or before December 31, 2024. The Company is currently evaluating the pronouncement to determine the impact it may have on the Company's consolidated financial statements.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Apr. 01, 2023
Fair Value Disclosures [Abstract]
Summary of fair value measurements by level for the assets measured on a recurring basis	The following table summarizes fair value measurements by level for the assets measured at fair value on a recurring basis as of April 1, 2023, and October 1, 2022: April 1, 2023 Level 1 Level 2 Level 3 Total (In thousands) Assets: Money market funds (cash equivalents) $ 223,579 $ — $ — $ 223,579 October 1, 2022 Level 1 Level 2 Level 3 Total (In thousands) Assets: Money market funds (cash equivalents) $ 187,170 $ — $ — $ 187,170

Revenue and Geographic Inform_2

Revenue and Geographic Information (Tables)	6 Months Ended
	Apr. 01, 2023
Revenue from Contract with Customer [Abstract]
Disaggregation of revenue	Revenue by region is as follows: Three Months Ended Six Months Ended April 1, April 2, April 1, April 2, (In thousands) Americas $ 196,533 $ 238,193 $ 593,097 $ 612,006 Europe, Middle East and Africa (“EMEA”) 89,054 128,431 329,494 373,912 Asia Pacific (“APAC”) 18,586 33,157 54,161 78,344 Total revenue $ 304,173 $ 399,781 $ 976,752 $ 1,064,262 Revenue by significant countries is as follows: Three Months Ended Six Months Ended April 1, April 2, April 1, April 2, (In thousands) United States $ 181,877 $ 219,082 $ 547,851 $ 566,729 Other countries 122,296 180,699 428,901 497,533 Total revenue $ 304,173 $ 399,781 $ 976,752 $ 1,064,262 Revenue by major product category is as follows: Three Months Ended Six Months Ended April 1, April 2, April 1, April 2, (In thousands) Sonos speakers $ 241,180 $ 317,734 $ 780,377 $ 819,620 Sonos system products 44,091 61,220 158,525 195,965 Partner products and other revenue 18,902 20,827 37,850 48,677 Total revenue $ 304,173 $ 399,781 $ 976,752 $ 1,064,262

Balance Sheet Components (Table

Balance Sheet Components (Tables)	6 Months Ended
	Apr. 01, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Summary of accounts receivable	Accounts receivable, net of allowances Accounts receivable, net of allowances, consist of the following: April 1, October 1, (In thousands) Accounts receivable $ 112,019 $ 127,523 Allowance for credit losses ( 3,171 ) ( 2,744 ) Allowance for sales incentives ( 24,645 ) ( 23,573 ) Accounts receivable, net of allowances $ 84,203 $ 101,206
Schedule of inventories	Inventories, net, consist of the following: April 1, October 1, (In thousands) Finished goods $ 274,459 $ 406,657 Component parts 51,830 47,631 Inventories $ 326,289 $ 454,288
Schedule of goodwill	The following table presents the changes in carrying amount of goodwill during the six months ended April 1, 2023: (In thousands) Balance as of October 1, 2022 $ 77,300 Effect of exchange rate changes on goodwill 4,201 Balance as of April 1, 2023 $ 81,501
Schedule of finite-lived intangible assets, future amortization expense	The following table reflects the changes in the net carrying amount of the components of intangible assets associated with the Company's acquisition activity: April 1, 2023 Gross Carrying Amount Accumulated Amortization Impact of FX Net Carrying Value Weighted-Average Remaining Life (In thousands, except weighted-average remaining life) Trade name $ 451 $ ( 71 ) $ ( 1 ) $ 379 5.00 Technology-based 31,480 ( 8,640 ) — 22,840 5.19 Total finite-lived intangible assets 31,931 ( 8,711 ) ( 1 ) 23,219 5.19 In-process research and development not subject to amortization 71,759 — ( 205 ) 71,554 Total intangible assets $ 103,690 $ ( 8,711 ) $ ( 206 ) $ 94,773 The following table summarizes the estimated future amortization expense of the Company's intangible assets as of April 1, 2023: Fiscal years ending Future Amortization Expense (In thousands) Remainder of fiscal 2023 $ 2,986 2024 5,971 2025 3,371 2026 3,041 2027 3,026 2028 and there after 4,824 Total future amortization expense $ 23,219
Schedule of accrued expenses	Accrued expenses consisted of the following: April 1, October 1, (In thousands) Accrued inventory and supply chain costs $ 40,213 $ 51,011 Accrued general and administrative expenses 14,811 21,634 Accrued advertising and marketing 10,982 21,292 Accrued taxes 5,076 7,081 Accrued product development 3,313 8,168 Other accrued payables 1,992 104 Total accrued expenses $ 76,387 $ 109,290
Changes in deferred balances and expected revenue recognition	The following table presents the changes in the Company’s deferred revenue for the six months ended April 1, 2023, and April 2, 2022: April 1, April 2, (In thousands) Deferred revenue, beginning of period $ 83,470 $ 89,498 Recognition of revenue included in beginning of period deferred revenue ( 16,186 ) ( 28,927 ) Revenue deferred, net of revenue recognized on contracts in the respective period 14,443 16,063 Deferred revenue, end of period $ 81,727 $ 76,634
Remaining performance obligation	The Company expects the following recognition of deferred revenue as of April 1, 2023: For the fiscal years ending 2023 2024 2025 2026 2027 and Total (In thousands) Deferred revenue expected to be recognized $ 10,391 $ 18,190 $ 15,892 $ 13,497 $ 23,757 $ 81,727
Schedule of other current liabilities	Other current liabilities consist of the following: April 1, October 1, (In thousands) Reserve for returns $ 15,674 $ 18,263 Short-term operating lease liabilities 10,949 10,532 Warranty liability 8,993 5,771 Other 6,250 5,083 Total other current liabilities $ 41,866 $ 39,649
Schedule of product warranty liability	The following table presents the changes in the Company’s warranty liability for the six months ended April 1, 2023, and April 2, 2022: April 1, April 2, (In thousands) Warranty liability, beginning of period $ 5,771 $ 5,604 Provision for warranties issued during the period 7,892 7,082 Settlements of warranty claims during the period ( 4,670 ) ( 3,930 ) Warranty liability, end of period $ 8,993 $ 8,756

Stock-based Compensation (Table

Stock-based Compensation (Tables)	6 Months Ended
	Apr. 01, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of stock option activity	The summary of the Company’s stock option activity is as follows: Number of Options Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term Aggregate Intrinsic Value (In years) (In thousands) Outstanding at October 1, 2022 10,802,882 $ 13.37 4.5 $ 10,956 Exercised ( 1,621,326 ) 10.85 Forfeited ( 20,943 ) 15.19 Outstanding at April 1, 2023 9,160,613 $ 13.82 4.1 $ 53,162
Schedule of restricted stock unit activity	The summary of the Company’s RSU activity is as follows Number of Units Weighted-Average Grant Date Fair Value Aggregate Intrinsic Value (In thousands) Outstanding at October 1, 2022 8,308,177 $ 19.25 $ 115,484 Granted 4,852,623 17.54 Released ( 2,273,828 ) 16.23 Forfeited ( 607,619 ) 18.19 Outstanding at April 1, 2023 10,279,353 $ 19.17 $ 201,681 At April 1, 2023 Units expected to vest 8,746,943 $ 19.06 $ 171,615
Schedule of performance stock units activity	The summary of the Company’s PSU activity is as follows: Number of Units Weighted-Average Grant Date Fair Value Aggregate Intrinsic Value (In thousands) Outstanding at October 1, 2022 398,077 $ 26.96 $ 5,533 Granted 249,370 17.54 Vested ( 263,158 ) 26.26 Forfeited ( 51,292 ) 20.49 Outstanding at April 1, 2023 332,997 $ 21.46 $ 6,533
Schedule of stock-based compensation expense	Total stock-based compensation expense by functional category was as follows: Three Months Ended Six Months Ended April 1, April 2, April 1, April 2, (In thousands) Cost of revenue $ 581 $ 377 $ 1,151 $ 705 Research and development 9,565 8,091 18,716 14,829 Sales and marketing 4,475 4,177 8,588 7,824 General and administrative 6,404 8,580 12,765 15,326 Total stock-based compensation expense $ 21,025 $ 21,225 $ 41,220 $ 38,684

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	6 Months Ended
	Apr. 01, 2023
Earnings Per Share [Abstract]
Schedule of net income (loss) per share	The following table sets forth the computation of the Company’s basic and diluted net income (loss) per share attributable to common stockholders: Three Months Ended Six Months Ended April 1, April 2, April 1, April 2, (In thousands, except share and per share data) Numerator: Net income (loss) attributable to common stockholders - basic and diluted $ ( 30,652 ) $ 8,566 $ 44,537 $ 132,047 Denominator: Weighted-average shares of common stock—basic 127,952,875 128,112,234 127,582,560 127,887,530 Effect of potentially dilutive stock options — 6,367,917 2,263,141 7,265,077 Effect of RSUs — 4,976,580 2,941,691 5,641,563 Effect of PSUs — 185,839 46,704 188,339 Weighted-average shares of common stock—diluted 127,952,875 139,642,570 132,834,096 140,982,509 Net income (loss) per share attributable to common stockholders: Basic $ ( 0.24 ) $ 0.07 $ 0.35 $ 1.03 Diluted $ ( 0.24 ) $ 0.06 $ 0.34 $ 0.94
Schedule of antidilutive securities	The following potentially dilutive shares were excluded from the computation of diluted net income (loss) per share attributable to common stockholders because including them would have been antidilutive: Three Months Ended Six Months Ended April 1, April 2, April 1, April 2, Stock options to purchase common stock 9,606,088 6,360,832 7,753,514 6,099,887 Restricted stock units 11,016,316 5,024,253 7,629,223 4,277,081 Performance stock units 251,004 115,668 123,142 113,169 Total 20,873,408 11,500,753 15,505,879 10,490,137

Business Overview and Basis o_3

Business Overview and Basis of Presentation (Details)	Apr. 01, 2023 Country
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of countries where products are distributed	60

Fair Value Measurements (Detail

Fair Value Measurements (Details) - Money Market Funds - USD ($) $ in Thousands	Apr. 01, 2023	Oct. 01, 2022
Assets:
Money market funds (cash equivalents)	$ 223,579	$ 187,170
Level 1
Assets:
Money market funds (cash equivalents)	223,579	187,170
Level 2
Assets:
Money market funds (cash equivalents)	0	0
Level 3
Assets:
Money market funds (cash equivalents)	$ 0	$ 0

Revenue and Geographic Inform_3

Revenue and Geographic Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 01, 2023	Apr. 02, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 304,173	$ 399,781	$ 976,752	$ 1,064,262
Sonos speakers
Disaggregation of Revenue [Line Items]
Revenue	241,180	317,734	780,377	819,620
Sonos system products
Disaggregation of Revenue [Line Items]
Revenue	44,091	61,220	158,525	195,965
Partner products and other revenue
Disaggregation of Revenue [Line Items]
Revenue	18,902	20,827	37,850	48,677
Americas
Disaggregation of Revenue [Line Items]
Revenue	196,533	238,193	593,097	612,006
Europe, Middle East and Africa (“EMEA”)
Disaggregation of Revenue [Line Items]
Revenue	89,054	128,431	329,494	373,912
Asia Pacific (“APAC”)
Disaggregation of Revenue [Line Items]
Revenue	18,586	33,157	54,161	78,344
United States
Disaggregation of Revenue [Line Items]
Revenue	181,877	219,082	547,851	566,729
Other countries
Disaggregation of Revenue [Line Items]
Revenue	$ 122,296	$ 180,699	$ 428,901	$ 497,533

Balance Sheet Components - Acco

Balance Sheet Components - Accounts receivable, net of allowances (Details) - USD ($) $ in Thousands	Apr. 01, 2023	Oct. 01, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accounts receivable	$ 112,019	$ 127,523
Allowance for credit losses	(3,171)	(2,744)
Allowance for sales incentives	(24,645)	(23,573)
Accounts receivable, net of allowances	$ 84,203	$ 101,206

Balance Sheet Components - Inve

Balance Sheet Components - Inventories (Details) - USD ($) $ in Thousands	Apr. 01, 2023	Oct. 01, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Finished goods	$ 274,459	$ 406,657
Component parts	51,830	47,631
Inventories	$ 326,289	$ 454,288

Balance Sheet Components - Good

Balance Sheet Components - Goodwill (Details) $ in Thousands	6 Months Ended
	Apr. 01, 2023 USD ($)
Goodwill [Roll Forward]
Goodwill beginning balance	$ 77,300
Effect of exchange rate changes on goodwill	4,201
Goodwill ending balance	$ 81,501

Balance Sheet Components - Fini

Balance Sheet Components - Finite-lived intangible assets, future amortization expense (Details) - USD ($) $ in Thousands	6 Months Ended
	Apr. 01, 2023	Oct. 01, 2022
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 31,931
Accumulated Amortization	(8,711)
Net Carrying Value	23,219
Finite lived intangible assets, impact	(1)
In-process research and development not subject to amortization, impact	(206)
In-process research and development not subject to amortization, Net	71,554	$ 64,680
Intangible assets, gross carrying amount (excluding goodwill)	103,690
Intangible assets, net carrying value (excluding goodwill)	$ 94,773
Weighted-Average Remaining Life	5 years 2 months 8 days
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Remainder of fiscal 2023	$ 2,986
2024	5,971
2025	3,371
2026	3,041
2027	3,026
2028 and there after	4,824
Net Carrying Value	23,219
Trade name
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	451
Accumulated Amortization	(71)
Net Carrying Value	379
Finite lived intangible assets, impact	$ (1)
Weighted-Average Remaining Life	5 years
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Net Carrying Value	$ 379
In-process research and development not subject to amortization
Finite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible assets (excluding goodwill)	71,759
In-process research and development not subject to amortization, impact	(205)
In-process research and development not subject to amortization, Net	71,554
Technology
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	31,480
Accumulated Amortization	(8,640)
Net Carrying Value	22,840
Finite lived intangible assets, impact
Weighted-Average Remaining Life	5 years 2 months 8 days
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Net Carrying Value	$ 22,840

Balance Sheet Components - Addi

Balance Sheet Components - Additional Information (Details) - USD ($) $ in Millions		3 Months Ended	6 Months Ended
	Oct. 01, 2022	Apr. 01, 2023	Apr. 01, 2023	Apr. 02, 2022
Business Acquisition [Line Items]
Weighted-average useful life			5 years 2 months 8 days
Recognition of revenue			$ 9.2	$ 18.8
Inventory write down	$ 8.8		19.3
Capitalized costs	21.7	$ 19.8	19.8
Amortization expenses		1	1.9
Accumulated amortization	$ 2.5	$ 4.4	$ 4.4

Balance Sheet Components - Accr

Balance Sheet Components - Accrued expenses (Details) - USD ($) $ in Thousands	Apr. 01, 2023	Oct. 01, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued inventory and supply chain costs	$ 40,213	$ 51,011
Accrued general and administrative expenses	14,811	21,634
Accrued advertising and marketing	10,982	21,292
Accrued taxes	5,076	7,081
Accrued product development	3,313	8,168
Other accrued payables	1,992	104
Total accrued expenses	$ 76,387	$ 109,290

Balance Sheet Components - Chan

Balance Sheet Components - Change in deferred revenue (Details) - USD ($) $ in Thousands	6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Contract with Customer, Liability [Roll Forward]
Deferred revenue, beginning of period	$ 83,470	$ 89,498
Recognition of revenue included in beginning of period deferred revenue	(16,186)	(28,927)
Revenue deferred, net of revenue recognized on contracts in the respective period	14,443	16,063
Deferred revenue, end of period	$ 81,727	$ 76,634

Balance Sheet Components - Expe

Balance Sheet Components - Expected revenue recognition (Details) $ in Thousands	Apr. 01, 2023 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue expected to be recognized	$ 81,727
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-02
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue expected to be recognized	$ 10,391
Performance obligations expected to be satisfied in	6 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue expected to be recognized	$ 18,190
Performance obligations expected to be satisfied in	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-09-29
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue expected to be recognized	$ 15,892
Performance obligations expected to be satisfied in	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-09-28
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue expected to be recognized	$ 13,497
Performance obligations expected to be satisfied in	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-09-27
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue expected to be recognized	$ 23,757
Performance obligations expected to be satisfied in

Balance Sheet Components - Ex_2

Balance Sheet Components - Expected revenue recognition 1 (Details) $ in Thousands	Apr. 01, 2023 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue expected to be recognized	$ 81,727

Balance Sheet Components - Othe

Balance Sheet Components - Other current liabilities (Details) - USD ($) $ in Thousands	Apr. 01, 2023	Oct. 01, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Reserve for returns	$ 15,674	$ 18,263
Short-term operating lease liabilities	$ 10,949	$ 10,532
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Total other current liabilities	Total other current liabilities
Warranty liability	$ 8,993	$ 5,771
Other	6,250	5,083
Total other current liabilities	$ 41,866	$ 39,649

Balance Sheet Components - Prod

Balance Sheet Components - Product Warranties (Details) - USD ($) $ in Thousands	6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Movement in Standard Product Warranty Accrual [Roll Forward]
Warranty liability, beginning of period	$ 5,771	$ 5,604
Provision for warranties issued during the period	7,892	7,082
Settlements of warranty claims during the period	(4,670)	(3,930)
Warranty liability, end of period	$ 8,993	$ 8,756

Debt - Additional Information (

Debt - Additional Information (Details) - Credit Facility - Revolving Credit Facility - USD ($) $ in Millions	Oct. 13, 2021	Apr. 01, 2023
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 100
Term of debt	5 years
Undrawn letters of credit		$ 3
Minimum
Debt Instrument [Line Items]
Commitment fee percentage	0.20%
Maximum
Debt Instrument [Line Items]
Commitment fee percentage	0.275%
Base Rate
Debt Instrument [Line Items]
Interest rate, spread on variable rate	1%

Commitments and Contingencies -

Commitments and Contingencies - Textual (Details) $ in Millions		3 Months Ended	6 Months Ended
	Mar. 10, 2017 Patent	Apr. 01, 2023 USD ($)	Apr. 01, 2023 USD ($)
Loss Contingencies [Line Items]
Commitments to suppliers		$ 169	$ 169
Commitments to suppliers expected to be paid			2 years
Tariff refund		4.1	$ 4.1
Implicit, LLC
Loss Contingencies [Line Items]
Loss contingency, patents allegedly infringed upon, number | Patent	2
Government
Loss Contingencies [Line Items]
Income tax examination, refund		2	6.4
Minimum
Loss Contingencies [Line Items]
Commitments to suppliers		106	106
Maximum
Loss Contingencies [Line Items]
Commitments to suppliers		$ 141	$ 141

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($) $ / shares in Units, $ in Millions	6 Months Ended
	Apr. 01, 2023	Nov. 16, 2022
Equity [Abstract]
Stock repurchase program, authorized value		$ 100
Purchase of treasury stock (in shares)	1,616,155
Purchase price of common stock	$ 30.1
Average price per share (in dollars per share)	$ 18.58
Remaining authorized repurchase amount	$ 69.9
Retirement of treasury stock (in shares)	3,613,807

Stock-based Compensation - Addi

Stock-based Compensation - Additional Information (Details) - USD ($)	1 Months Ended	6 Months Ended	12 Months Ended
	Jul. 31, 2018	Apr. 01, 2023	Oct. 01, 2022
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period		48 months
Exercisable period		10 years
Unrecognized stock-based compensation expense		$ 0	$ 400,000
Unrecognized stock-based compensation expense, period of recognition			2 months 12 days
Restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period		4 years
Unrecognized stock-based compensation expense		$ 148,200,000	$ 120,600,000
Unrecognized stock-based compensation expense, period of recognition		2 years 8 months 12 days	2 years 6 months
Performance Share Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized stock-based compensation expense		$ 2,000,000	$ 400,000
Unrecognized stock-based compensation expense, period of recognition		1 year 8 months 12 days	7 months 6 days
Performance achievement adjustments		12,895
2018 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of outstanding stock maximum	5%

Stock-based Compensation - Stoc

Stock-based Compensation - Stock Option Activity (Details) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Apr. 01, 2023 USD ($) $ / shares shares	Oct. 01, 2022 USD ($) $ / shares shares
Number of Options
Beginning balance (in shares) | shares	10,802,882
Exercised (in shares) | shares	(1,621,326)
Forfeited (in shares) | shares	(20,943)
Ending balance (in shares) | shares	9,160,613	10,802,882
Weighted-Average Exercise Price
Beginning balance (in USD per share) | $ / shares	$ 13.37
Exercised (in USD per share) | $ / shares	10.85
Forfeited (in USD per share) | $ / shares	15.19
Ending balance (in USD per share) | $ / shares	$ 13.82	$ 13.37
Additional Information
Weighted-Average Remaining Contractual Term	4 years 1 month 6 days	4 years 6 months
Aggregate Intrinsic Value | $	$ 53,162	$ 10,956

Stock-Based Compensation - Rest

Stock-Based Compensation - Restricted Stock Unit Activity (Details) - Restricted stock units $ / shares in Units, $ in Thousands	6 Months Ended
	Apr. 01, 2023 USD ($) $ / shares shares
Number of Units
Outstanding, beginning balance (in shares) | shares	8,308,177
Granted (in shares) | shares	4,852,623
Released (in shares) | shares	(2,273,828)
Forfeited (in shares) | shares	(607,619)
Outstanding, ending balance (in shares) | shares	10,279,353
Units expected to vest (in shares) | shares	8,746,943
Weighted-Average Grant Date Fair Value
Outstanding, beginning balance (in USD per share) | $ / shares	$ 19.25
Granted (in USD per share) | $ / shares	17.54
Released (in USD per share) | $ / shares	16.23
Forfeited (in USD per share) | $ / shares	18.19
Outstanding, ending balance (in USD per share) | $ / shares	19.17
Vested and expected to vest - Weighted Average Exercise Price (in dollars per share) | $ / shares	$ 19.06
Additional Information
Aggregate Intrinsic Value, beginning balance | $	$ 115,484
Aggregate Intrinsic Value, ending balance | $	201,681
Vested and expected to vest - Weighted Average Intrinsic Value | $	$ 171,615

Stock-based Compensation - Perf

Stock-based Compensation - Performance Stock Unit Activity (Details) - Performance Share Units $ / shares in Units, $ in Thousands	6 Months Ended
	Apr. 01, 2023 USD ($) $ / shares shares
Number of Units
Outstanding, beginning balance (in shares) | shares	398,077
Granted (in shares) | shares	249,370
Vested (in shares) | shares	(263,158)
Forfeited (in shares) | shares	(51,292)
Outstanding, ending balance (in shares) | shares	332,997
Weighted-Average Grant Date Fair Value
Outstanding, beginning balance (in USD per share) | $ / shares	$ 26.96
Granted (in USD per share) | $ / shares	17.54
Vested (in USD per share) | $ / shares	26.26
Forfeited (in USD per share) | $ / shares	20.49
Outstanding, ending balance (in USD per share) | $ / shares	$ 21.46
Additional Information
Aggregate Intrinsic Value, beginning balance | $	$ 5,533
Aggregate Intrinsic Value, ending balance | $	$ 6,533

Stock-based Compensation - St_2

Stock-based Compensation - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 01, 2023	Apr. 02, 2022
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 21,025	$ 21,225	$ 41,220	$ 38,684
Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	581	377	1,151	705
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	9,565	8,091	18,716	14,829
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	4,475	4,177	8,588	7,824
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 6,404	$ 8,580	$ 12,765	$ 15,326

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 01, 2023	Apr. 02, 2022
Income Tax Disclosure [Abstract]
Provision for (benefit from) income taxes	$ (26,377)	$ (772)	$ 10,124	$ 6,874

Net Income (Loss) Per Share - C

Net Income (Loss) Per Share - Computation of Basic and Diluted Net Income (Loss) Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				6 Months Ended
	Apr. 01, 2023	Dec. 31, 2022	Apr. 02, 2022	Jan. 01, 2022	Apr. 01, 2023	Apr. 02, 2022
Numerator:
Net income (loss)	$ (30,652)	$ 75,188	$ 8,566	$ 123,481	$ 44,537	$ 132,047
Denominator:
Weighted-average shares of common stock - basic (in shares)	127,952,875		128,112,234		127,582,560	127,887,530
Weighted-average shares of common stock - diluted (in shares)	127,952,875		139,642,570		132,834,096	140,982,509
Net income (loss) per share attributable to common stockholders:
Net income (loss) per share attributable to common stockholders - basic (in USD per share)	$ (0.24)		$ 0.07		$ 0.35	$ 1.03
Net income (loss) per share attributable to common stockholders - diluted (in USD per share)	$ (0.24)		$ 0.06		$ 0.34	$ 0.94
Stock Options
Denominator:
Effect of potentially dilutive stock options, RSUs, and PSUs (in shares)			6,367,917		2,263,141	7,265,077
Restricted stock units
Denominator:
Effect of potentially dilutive stock options, RSUs, and PSUs (in shares)			4,976,580		2,941,691	5,641,563
Performance Share Units
Denominator:
Effect of potentially dilutive stock options, RSUs, and PSUs (in shares)			185,839		46,704	188,339

Net Income (Loss) Per Share - A

Net Income (Loss) Per Share - Antidilutive Securities (Details) - shares	3 Months Ended		6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 01, 2023	Apr. 02, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially antidilutive securities (in shares)	20,873,408	11,500,753	15,505,879	10,490,137
Stock options to purchase common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially antidilutive securities (in shares)	9,606,088	6,360,832	7,753,514	6,099,887
Restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially antidilutive securities (in shares)	11,016,316	5,024,253	7,629,223	4,277,081
Performance stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially antidilutive securities (in shares)	251,004	115,668	123,142	113,169

Retirement Plans (Details)

Retirement Plans (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 01, 2023	Apr. 02, 2022
Retirement Benefits [Abstract]
Employer contribution	$ 2.4	$ 2.1	$ 4.7	$ 4